Plain-English translation of NCT06572540 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing cryoablation—a treatment that uses extreme cold to destroy lung cancer tumors—in people with early-stage peripheral lung cancer. Researchers want to compare two different ways of delivering this freezing treatment: one through the chest wall (guided by CT scans) and one through the airways using a bronchoscope (a thin camera). Both methods have shown promise, but this study will help doctors understand which approach works better and is safest.
While cryoablation has proven effective for treating early lung cancer, there is limited research directly comparing the two delivery methods side-by-side. This trial aims to fill that gap by providing strong evidence about which technique offers the best results and fewest complications for patients.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive one of the two freezing techniques. If you receive the chest-wall method, you'll have a needle inserted through your chest wall guided by CT imaging to freeze your tumor. If you receive the airway method, a flexible tube with a freezing probe will be passed down your windpipe guided by a bronchoscope. After treatment, you'll return for follow-up visits at 6 months, 12 months, and up to 3 years to check how well the tumor was destroyed and to monitor for any side effects.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China